Cart summary

You have no items in your shopping cart.

WZ4002-hydroxy

SKU: orb1985188

Description

WZ4002-hydroxyl, a WZ4002 analogue with hydroxyl replacing methoxy, is identified in 50% of gefitinib- or erlotinib-resistant patients. WZ4002 features a distinct covalent pyrimidine scaffold. It is used in research on EGFR-driven cancers, including in vitro and in vivo studies of resistance mechanisms.

Images & Validation

Key Properties

MW480.95
FormulaC24H25ClN6O3
SMILESC=CC(NC1=CC=CC(OC2=NC(NC3=CC=C(C=C3O)N4CCN(CC4)C)=NC=C2Cl)=C1)=O
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

WZ4002-hydroxy (orb1985188)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%